TesoRx Pharma Lands $10,000,000 Series B Financing Round

  • Feed Type
  • Date
    8/6/2014
  • Company Name
    TesoRx Pharma
  • Mailing Address
    325 Sharon Park Drive Menlo Park, CA 94025 USA
  • Company Description
    The founders of TesoRx bring vast experience in both pharmaceutical research and business to their leadership of the company’s executive management team. With a strong track record of taking products from bench to market, establishing pharmaceutical manufacturing facilities and managing successful companies.
  • Website
    http://www.tesorx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The funding will be used to prepare for Phase 3 trials for TSX-002, an oral formulation of unmodified testosterone, to advance its pipeline and build out its commercial manufacturing facilities.
  • M&A Terms
  • Venture Investor